Uterine Cervical Neoplasms

• 

  Subject Areas on Research

  • "You just do your part. God will do the rest.": spirituality and culture in the medical encounter. 
  • 6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-alpha-reductase activity. 
  • A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study. 
  • A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. 
  • A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. 
  • A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. 
  • A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. 
  • A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. 
  • A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. 
  • A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. 
  • A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening. 
  • Abnormal Fhit expression in malignant and premalignant lesions of the cervix. 
  • Abnormal outcomes following cervical cancer screening: event duration and health utility loss. 
  • Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. 
  • Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. 
  • Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnership. 
  • Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. 
  • Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. 
  • Advances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer. 
  • Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. 
  • Age-specific occurrence of HPV16- and HPV18-related cervical cancer. 
  • American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. 
  • Analysis of results of radiation therapy for stage IB carcinoma of the cervix. 
  • Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer? 
  • Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. 
  • Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer. 
  • Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. 
  • Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. 
  • Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. 
  • Authors' reply: Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study: population and statistical queries. 
  • Awareness of Cervical Cancer Causes and Predeterminants of Likelihood to Screen Among Women in Haiti. 
  • Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. 
  • Barriers to Breast and Cervical Cancer Screening in Singapore: a Mixed Methods Analysis. 
  • Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey. 
  • Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program. 
  • Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective? 
  • Bilateral pelvic lymph node metastases in a case of FIGO stage IA(1) adenocarcinoma of the cervix. 
  • Blue nevus of the cervix. 
  • Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. 
  • CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines. 
  • Can screening older patients for cancer save lives? 
  • Cancer risk in women exposed to diethylstilbestrol in utero. 
  • Cancer screening behaviors and attitudes of women in southeastern Minnesota. 
  • Cancer screening practices among women in a community health center population. 
  • Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. 
  • Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. 
  • Carcinoma of the uterine cervix: a 3D - CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. 
  • Cardiac metastasis from carcinoma of the cervix: report of two cases. 
  • Cell cycle studies of cyclocreatine, a new anticancer agent. 
  • Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya. 
  • Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It? 
  • Cervical adenoid cystic carcinoma associated with ascites. 
  • Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods. 
  • Cervical cancer. 
  • Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. 
  • Cervical cytology screening. 
  • Cervical intraepithelial neoplasia in HIV-infected women in a southeastern US population. 
  • Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. 
  • Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. 
  • Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. 
  • Chapter 19: Cost-effectiveness of cervical cancer screening. 
  • Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol. 
  • Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. 
  • Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. 
  • Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Coital risk factors for cervical cancer. Sexual activity among white middle class women. 
  • Comparison of histologic and colposcopic findings in DES-exposed females. 
  • Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses. 
  • Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. 
  • Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. 
  • Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening. 
  • Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). 
  • Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. 
  • Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. 
  • Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. 
  • Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. 
  • Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. 
  • Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. 
  • Decision science and cervical cancer. 
  • Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings. 
  • Design of a plastic minicolpostat applicator with shields. 
  • Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. 
  • Disparities in Cervical Cancer Incidence and Mortality: Can Epigenetics Contribute to Eliminating Disparities? 
  • Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. 
  • Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. 
  • Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling. 
  • Evaluation of cervical cytology. 
  • Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. 
  • Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. 
  • Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader. 
  • Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. 
  • FDG-PET for management of cervical and ovarian cancer. 
  • Factors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals. 
  • Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. 
  • Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya. 
  • Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology. 
  • Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. 
  • Glassy cell carcinoma of the cervix. 
  • Goblet-cell mucinous epithelium lining the endometrium and endocervix: evidence of metastasis from an appendiceal primary tumor through the use of cytokeratin-7 and -20 immunostains. 
  • HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA. 
  • HPV vaccines: now that they're here, how do we maximize their benefit? 
  • High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease. 
  • Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas. 
  • Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program. 
  • Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. 
  • Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. 
  • Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. 
  • Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. 
  • Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. 
  • Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 
  • Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening. 
  • Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999-2004. 
  • Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study. 
  • Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. 
  • Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007. 
  • Improving the sensitivity of cervical cytology: what are the issues? 
  • In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). 
  • Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease. 
  • Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. 
  • Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). 
  • Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. 
  • Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. 
  • Incremental and average cost-effectiveness ratios: will physicians make a distinction? 
  • Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. 
  • Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act. 
  • International Image Concordance Study to Compare a Point-of-Care Tampon Colposcope With a Standard-of-Care Colposcope. 
  • Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta. 
  • Invasive and in situ cervical cancer reported to the vaccine adverse event reporting system (VAERS). 
  • Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. 
  • Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya. 
  • Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications. 
  • Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive Kenyan women. 
  • Major morbidity after pelvic exenteration: a seven-year experience. 
  • Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. 
  • Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? 
  • Men's knowledge and attitudes about cervical cancer screening in Kenya. 
  • Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies. 
  • Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. 
  • Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine. 
  • Molecular characterization of adenocarcinoma of the cervix. 
  • Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5. 
  • Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. 
  • Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. 
  • Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. 
  • Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. 
  • Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. 
  • Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES exposed progeny. 
  • Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. 
  • Oral contraceptive use and risk of cancer--response. 
  • PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. 
  • Pain predicts non-adherence to pap smear screening among middle-aged African American women. 
  • Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). 
  • Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study. 
  • Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. 
  • Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. 
  • Patterns of cervical cancer screening, diagnosis, and follow-up treatment in a state Medicaid fee-for-service population. 
  • Pediatricians are more supportive of the human papillomavirus vaccine than the general public. 
  • Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro. 
  • Peritoneal cytology and invasive carcinoma of the cervix. 
  • Portable colposcopy in low-resource settings. 
  • Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study. 
  • Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. 
  • Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. 
  • Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. 
  • Prenatal diethylstilbestrol exposure and human genital tract abnormalities. 
  • Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population. 
  • Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Psychometric validation and reliability analysis of a Spanish version of the patient satisfaction with cancer-related care measure: a patient navigation research program study. 
  • Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. 
  • Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy. 
  • Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam. 
  • Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes. 
  • Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. 
  • Radical hysterectomy in obese women. 
  • Rapid determination of oxygen saturation and vascularity for cancer detection. 
  • Recent developments in defining microinvasive and early invasive carcinoma of the uterine cervix. 
  • Relationship of epithelial ovarian cancer to other malignancies within families. 
  • Reproducibility of self-reported pap test utilization in middle-aged African-American women. 
  • Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya. 
  • Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. 
  • Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia. 
  • Safety of the loop electrosurgical excision procedure performed by clinical officers in an HIV primary care setting. 
  • Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. 
  • Screening and early detection among racial and ethnic minority women. 
  • Screening for cervical cancer: a modeling study for the US Preventive Services Task Force. 
  • Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). 
  • Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. 
  • Short birth intervals and uterine cervical cancer risk in Jamaican women. 
  • Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. 
  • Squamous cell neoplasia controversy in the female exposed to diethylstilbestrol. 
  • Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. 
  • Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. 
  • Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. 
  • Technologic advances for evaluation of cervical cytology: is newer better? 
  • The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. 
  • The association of oncogenic human papillomaviruses with urologic malignancy. The controversies and clinical implications. 
  • The clinical significance of blood transfusion at the time of radical hysterectomy. 
  • The current and future role of screening in the era of HPV vaccination. 
  • The economic impact of HPV vaccines: not just cervical cancer. 
  • The impact of health status on physicians' intentions to offer cancer screening to older women. 
  • The impact of human papillomavirus vaccination on cervical cancer prevention efforts. 
  • The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. 
  • The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. 
  • The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer. 
  • The influence of cost-effectiveness information on physicians' cancer screening recommendations. 
  • The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. 
  • The nucleolar localization domain of the catalytic subunit of human telomerase. 
  • The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The role of PET scanning in the detection of recurrent cervical cancer. 
  • The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network. 
  • The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. 
  • The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. 
  • Three-dimensional applicator system for carcinoma of the uterine cervix. 
  • Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. 
  • Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide. 
  • US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. 
  • Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. 
  • Utility scores and treatment preferences for clinical early-stage cervical cancer. 
  • Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy. 
  • Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. 
  • Villoglandular adenocarcinoma of the cervix: a case report. 
  • Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Moorman, Patricia Gripka, Professor in Community and Family Medicine, Duke Cancer Institute
  • Myers, Evan Robert, Walter L. Thomas Professor of Obstetrics and Gynecology in the School of Medicine, Obstetrics and Gynecology
  • Palmer, Gregory M., Associate Professor of Radiation Oncology, Radiation Oncology